Global Prostate Cancer Medicine Market Size, Status and Forecast 2024-2031

Report ID: 917235 | Published Date: Jan 2025 | No. of Page: 106 | Base Year: 2024 | Rating: 4.3 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Prostate Cancer Medicine Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 LHRH Antagonists
        1.2.3 LHRH Analogs
        1.2.4 Antiandrogens
        1.2.5 Pipeline Drugs for Hormonal Therapy
    1.3 Market by Application
        1.3.1 Global Prostate Cancer Medicine Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Hospitals
        1.3.3 Other
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Prostate Cancer Medicine Market Perspective (2016-2027)
    2.2 Prostate Cancer Medicine Growth Trends by Regions
        2.2.1 Prostate Cancer Medicine Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Prostate Cancer Medicine Historic Market Share by Regions (2016-2021)
        2.2.3 Prostate Cancer Medicine Forecasted Market Size by Regions (2022-2027)
    2.3 Prostate Cancer Medicine Industry Dynamic
        2.3.1 Prostate Cancer Medicine Market Trends
        2.3.2 Prostate Cancer Medicine Market Drivers
        2.3.3 Prostate Cancer Medicine Market Challenges
        2.3.4 Prostate Cancer Medicine Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Prostate Cancer Medicine Players by Revenue
        3.1.1 Global Top Prostate Cancer Medicine Players by Revenue (2016-2021)
        3.1.2 Global Prostate Cancer Medicine Revenue Market Share by Players (2016-2021)
    3.2 Global Prostate Cancer Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Prostate Cancer Medicine Revenue
    3.4 Global Prostate Cancer Medicine Market Concentration Ratio
        3.4.1 Global Prostate Cancer Medicine Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Prostate Cancer Medicine Revenue in 2020
    3.5 Prostate Cancer Medicine Key Players Head office and Area Served
    3.6 Key Players Prostate Cancer Medicine Product Solution and Service
    3.7 Date of Enter into Prostate Cancer Medicine Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Prostate Cancer Medicine Breakdown Data by Type
    4.1 Global Prostate Cancer Medicine Historic Market Size by Type (2016-2021)
    4.2 Global Prostate Cancer Medicine Forecasted Market Size by Type (2022-2027)

5 Prostate Cancer Medicine Breakdown Data by Application
    5.1 Global Prostate Cancer Medicine Historic Market Size by Application (2016-2021)
    5.2 Global Prostate Cancer Medicine Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Prostate Cancer Medicine Market Size (2016-2027)
    6.2 North America Prostate Cancer Medicine Market Size by Type
        6.2.1 North America Prostate Cancer Medicine Market Size by Type (2016-2021)
        6.2.2 North America Prostate Cancer Medicine Market Size by Type (2022-2027)
        6.2.3 North America Prostate Cancer Medicine Market Size by Type (2016-2027)
    6.3 North America Prostate Cancer Medicine Market Size by Application
        6.3.1 North America Prostate Cancer Medicine Market Size by Application (2016-2021)
        6.3.2 North America Prostate Cancer Medicine Market Size by Application (2022-2027)
        6.3.3 North America Prostate Cancer Medicine Market Size by Application (2016-2027)
    6.4 North America Prostate Cancer Medicine Market Size by Country
        6.4.1 North America Prostate Cancer Medicine Market Size by Country (2016-2021)
        6.4.2 North America Prostate Cancer Medicine Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Prostate Cancer Medicine Market Size (2016-2027)
    7.2 Europe Prostate Cancer Medicine Market Size by Type
        7.2.1 Europe Prostate Cancer Medicine Market Size by Type (2016-2021)
        7.2.2 Europe Prostate Cancer Medicine Market Size by Type (2022-2027)
        7.2.3 Europe Prostate Cancer Medicine Market Size by Type (2016-2027)
    7.3 Europe Prostate Cancer Medicine Market Size by Application
        7.3.1 Europe Prostate Cancer Medicine Market Size by Application (2016-2021)
        7.3.2 Europe Prostate Cancer Medicine Market Size by Application (2022-2027)
        7.3.3 Europe Prostate Cancer Medicine Market Size by Application (2016-2027)
    7.4 Europe Prostate Cancer Medicine Market Size by Country
        7.4.1 Europe Prostate Cancer Medicine Market Size by Country (2016-2021)
        7.4.2 Europe Prostate Cancer Medicine Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Prostate Cancer Medicine Market Size (2016-2027)
    8.2 Asia-Pacific Prostate Cancer Medicine Market Size by Type
        8.2.1 Asia-Pacific Prostate Cancer Medicine Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Prostate Cancer Medicine Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Prostate Cancer Medicine Market Size by Type (2016-2027)
    8.3 Asia-Pacific Prostate Cancer Medicine Market Size by Application
        8.3.1 Asia-Pacific Prostate Cancer Medicine Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Prostate Cancer Medicine Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Prostate Cancer Medicine Market Size by Application (2016-2027)
    8.4 Asia-Pacific Prostate Cancer Medicine Market Size by Region
        8.4.1 Asia-Pacific Prostate Cancer Medicine Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Prostate Cancer Medicine Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Prostate Cancer Medicine Market Size (2016-2027)
    9.2 Latin America Prostate Cancer Medicine Market Size by Type
        9.2.1 Latin America Prostate Cancer Medicine Market Size by Type (2016-2021)
        9.2.2 Latin America Prostate Cancer Medicine Market Size by Type (2022-2027)
        9.2.3 Latin America Prostate Cancer Medicine Market Size by Type (2016-2027)
    9.3 Latin America Prostate Cancer Medicine Market Size by Application
        9.3.1 Latin America Prostate Cancer Medicine Market Size by Application (2016-2021)
        9.3.2 Latin America Prostate Cancer Medicine Market Size by Application (2022-2027)
        9.3.3 Latin America Prostate Cancer Medicine Market Size by Application (2016-2027)
    9.4 Latin America Prostate Cancer Medicine Market Size by Country
        9.4.1 Latin America Prostate Cancer Medicine Market Size by Country (2016-2021)
        9.4.2 Latin America Prostate Cancer Medicine Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Prostate Cancer Medicine Market Size (2016-2027)
    10.2 Middle East & Africa Prostate Cancer Medicine Market Size by Type
        10.2.1 Middle East & Africa Prostate Cancer Medicine Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Prostate Cancer Medicine Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Prostate Cancer Medicine Market Size by Type (2016-2027)
    10.3 Middle East & Africa Prostate Cancer Medicine Market Size by Application
        10.3.1 Middle East & Africa Prostate Cancer Medicine Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Prostate Cancer Medicine Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Prostate Cancer Medicine Market Size by Application (2016-2027)
    10.4 Middle East & Africa Prostate Cancer Medicine Market Size by Country
        10.4.1 Middle East & Africa Prostate Cancer Medicine Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Prostate Cancer Medicine Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 AstraZeneca plc
        11.1.1 AstraZeneca plc Company Details
        11.1.2 AstraZeneca plc Business Overview
        11.1.3 AstraZeneca plc Prostate Cancer Medicine Introduction
        11.1.4 AstraZeneca plc Revenue in Prostate Cancer Medicine Business (2016-2021)
        11.1.5 AstraZeneca plc Recent Development
    11.2 Active Biotech
        11.2.1 Active Biotech Company Details
        11.2.2 Active Biotech Business Overview
        11.2.3 Active Biotech Prostate Cancer Medicine Introduction
        11.2.4 Active Biotech Revenue in Prostate Cancer Medicine Business (2016-2021)
        11.2.5 Active Biotech Recent Development
    11.3 Bristol Myers-Squibb
        11.3.1 Bristol Myers-Squibb Company Details
        11.3.2 Bristol Myers-Squibb Business Overview
        11.3.3 Bristol Myers-Squibb Prostate Cancer Medicine Introduction
        11.3.4 Bristol Myers-Squibb Revenue in Prostate Cancer Medicine Business (2016-2021)
        11.3.5 Bristol Myers-Squibb Recent Development
    11.4 Teva Pharmaceuticals Industries Ltd.
        11.4.1 Teva Pharmaceuticals Industries Ltd. Company Details
        11.4.2 Teva Pharmaceuticals Industries Ltd. Business Overview
        11.4.3 Teva Pharmaceuticals Industries Ltd. Prostate Cancer Medicine Introduction
        11.4.4 Teva Pharmaceuticals Industries Ltd. Revenue in Prostate Cancer Medicine Business (2016-2021)
        11.4.5 Teva Pharmaceuticals Industries Ltd. Recent Development
    11.5 Johnson & Johnson
        11.5.1 Johnson & Johnson Company Details
        11.5.2 Johnson & Johnson Business Overview
        11.5.3 Johnson & Johnson Prostate Cancer Medicine Introduction
        11.5.4 Johnson & Johnson Revenue in Prostate Cancer Medicine Business (2016-2021)
        11.5.5 Johnson & Johnson Recent Development
    11.6 Pfizer Inc.
        11.6.1 Pfizer Inc. Company Details
        11.6.2 Pfizer Inc. Business Overview
        11.6.3 Pfizer Inc. Prostate Cancer Medicine Introduction
        11.6.4 Pfizer Inc. Revenue in Prostate Cancer Medicine Business (2016-2021)
        11.6.5 Pfizer Inc. Recent Development
    11.7 Bayer AG
        11.7.1 Bayer AG Company Details
        11.7.2 Bayer AG Business Overview
        11.7.3 Bayer AG Prostate Cancer Medicine Introduction
        11.7.4 Bayer AG Revenue in Prostate Cancer Medicine Business (2016-2021)
        11.7.5 Bayer AG Recent Development
    11.8 Abbott Laboratories
        11.8.1 Abbott Laboratories Company Details
        11.8.2 Abbott Laboratories Business Overview
        11.8.3 Abbott Laboratories Prostate Cancer Medicine Introduction
        11.8.4 Abbott Laboratories Revenue in Prostate Cancer Medicine Business (2016-2021)
        11.8.5 Abbott Laboratories Recent Development
    11.9 Astellas Pharma Inc.
        11.9.1 Astellas Pharma Inc. Company Details
        11.9.2 Astellas Pharma Inc. Business Overview
        11.9.3 Astellas Pharma Inc. Prostate Cancer Medicine Introduction
        11.9.4 Astellas Pharma Inc. Revenue in Prostate Cancer Medicine Business (2016-2021)
        11.9.5 Astellas Pharma Inc. Recent Development
    11.10 Roche Holding AG
        11.10.1 Roche Holding AG Company Details
        11.10.2 Roche Holding AG Business Overview
        11.10.3 Roche Holding AG Prostate Cancer Medicine Introduction
        11.10.4 Roche Holding AG Revenue in Prostate Cancer Medicine Business (2016-2021)
        11.10.5 Roche Holding AG Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Prostate Cancer Medicine Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of LHRH Antagonists
    Table 3. Key Players of LHRH Analogs
    Table 4. Key Players of Antiandrogens
    Table 5. Key Players of Pipeline Drugs for Hormonal Therapy
    Table 6. Global Prostate Cancer Medicine Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 7. Global Prostate Cancer Medicine Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 8. Global Prostate Cancer Medicine Market Size by Regions (2016-2021) & (US$ Million)
    Table 9. Global Prostate Cancer Medicine Market Share by Regions (2016-2021)
    Table 10. Global Prostate Cancer Medicine Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 11. Global Prostate Cancer Medicine Market Share by Regions (2022-2027)
    Table 12. Prostate Cancer Medicine Market Trends
    Table 13. Prostate Cancer Medicine Market Drivers
    Table 14. Prostate Cancer Medicine Market Challenges
    Table 15. Prostate Cancer Medicine Market Restraints
    Table 16. Global Prostate Cancer Medicine Revenue by Players (2016-2021) & (US$ Million)
    Table 17. Global Prostate Cancer Medicine Market Share by Players (2016-2021)
    Table 18. Global Top Prostate Cancer Medicine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prostate Cancer Medicine as of 2020)
    Table 19. Ranking of Global Top Prostate Cancer Medicine Companies by Revenue (US$ Million) in 2020
    Table 20. Global 5 Largest Players Market Share by Prostate Cancer Medicine Revenue (CR5 and HHI) & (2016-2021)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Prostate Cancer Medicine Product Solution and Service
    Table 23. Date of Enter into Prostate Cancer Medicine Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Prostate Cancer Medicine Market Size by Type (2016-2021) (US$ Million)
    Table 26. Global Prostate Cancer Medicine Revenue Market Share by Type (2016-2021)
    Table 27. Global Prostate Cancer Medicine Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 28. Global Prostate Cancer Medicine Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 29. Global Prostate Cancer Medicine Market Size Share by Application (2016-2021) & (US$ Million)
    Table 30. Global Prostate Cancer Medicine Revenue Market Share by Application (2016-2021)
    Table 31. Global Prostate Cancer Medicine Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 32. Global Prostate Cancer Medicine Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 33. North America Prostate Cancer Medicine Market Size by Type (2016-2021) (US$ Million)
    Table 34. North America Prostate Cancer Medicine Market Size by Type (2022-2027) & (US$ Million)
    Table 35. North America Prostate Cancer Medicine Market Size by Application (2016-2021) (US$ Million)
    Table 36. North America Prostate Cancer Medicine Market Size by Application (2022-2027) & (US$ Million)
    Table 37. North America Prostate Cancer Medicine Market Size by Country (2016-2021) & (US$ Million) 
    Table 38. North America Prostate Cancer Medicine Market Size by Country (2022-2027) & (US$ Million) 
    Table 39. Europe Prostate Cancer Medicine Market Size by Type (2016-2021) (US$ Million)
    Table 40. Europe Prostate Cancer Medicine Market Size by Type (2022-2027) & (US$ Million)
    Table 41. Europe Prostate Cancer Medicine Market Size by Application (2016-2021) (US$ Million)
    Table 42. Europe Prostate Cancer Medicine Market Size by Application (2022-2027) & (US$ Million)
    Table 43. Europe Prostate Cancer Medicine Market Size by Country (2016-2021) & (US$ Million) 
    Table 44. Europe Prostate Cancer Medicine Market Size by Country (2022-2027) & (US$ Million) 
    Table 45. Asia-Pacific Prostate Cancer Medicine Market Size by Type (2016-2021) (US$ Million)
    Table 46. Asia-Pacific Prostate Cancer Medicine Market Size by Type (2022-2027) & (US$ Million)
    Table 47. Asia-Pacific Prostate Cancer Medicine Market Size by Application (2016-2021) (US$ Million)
    Table 48. Asia-Pacific Prostate Cancer Medicine Market Size by Application (2022-2027) & (US$ Million)
    Table 49. Asia-Pacific Prostate Cancer Medicine Market Size by Region (2016-2021) & (US$ Million) 
    Table 50. Asia-Pacific Prostate Cancer Medicine Market Size by Region (2022-2027) & (US$ Million) 
    Table 51. Latin America Prostate Cancer Medicine Market Size by Type (2016-2021) (US$ Million)
    Table 52. Latin America Prostate Cancer Medicine Market Size by Type (2022-2027) & (US$ Million)
    Table 53. Latin America Prostate Cancer Medicine Market Size by Application (2016-2021) (US$ Million)
    Table 54. Latin America Prostate Cancer Medicine Market Size by Application (2022-2027) & (US$ Million)
    Table 55. Latin America Prostate Cancer Medicine Market Size by Country (2016-2021) & (US$ Million) 
    Table 56. Latin America Prostate Cancer Medicine Market Size by Country (2022-2027) & (US$ Million) 
    Table 57. Middle East & Africa Prostate Cancer Medicine Market Size by Type (2016-2021) (US$ Million)
    Table 58. Middle East & Africa Prostate Cancer Medicine Market Size by Type (2022-2027) & (US$ Million)
    Table 59. Middle East & Africa Prostate Cancer Medicine Market Size by Application (2016-2021) (US$ Million)
    Table 60. Middle East & Africa Prostate Cancer Medicine Market Size by Application (2022-2027) & (US$ Million)
    Table 61. Middle East & Africa Prostate Cancer Medicine Market Size by Country (2016-2021) & (US$ Million) 
    Table 62. Middle East & Africa Prostate Cancer Medicine Market Size by Country (2022-2027) & (US$ Million) 
    Table 63. AstraZeneca plc Company Details
    Table 64. AstraZeneca plc Business Overview
    Table 65. AstraZeneca plc Prostate Cancer Medicine Product
    Table 66. AstraZeneca plc Revenue in Prostate Cancer Medicine Business (2016-2021) & (US$ Million)
    Table 67. AstraZeneca plc Recent Development
    Table 68. Active Biotech Company Details
    Table 69. Active Biotech Business Overview
    Table 70. Active Biotech Prostate Cancer Medicine Product
    Table 71. Active Biotech Revenue in Prostate Cancer Medicine Business (2016-2021) & (US$ Million)
    Table 72. Active Biotech Recent Development
    Table 73. Bristol Myers-Squibb Company Details
    Table 74. Bristol Myers-Squibb Business Overview
    Table 75. Bristol Myers-Squibb Prostate Cancer Medicine Product
    Table 76. Bristol Myers-Squibb Revenue in Prostate Cancer Medicine Business (2016-2021) & (US$ Million)
    Table 77. Bristol Myers-Squibb Recent Development
    Table 78. Teva Pharmaceuticals Industries Ltd. Company Details
    Table 79. Teva Pharmaceuticals Industries Ltd. Business Overview
    Table 80. Teva Pharmaceuticals Industries Ltd. Prostate Cancer Medicine Product
    Table 81. Teva Pharmaceuticals Industries Ltd. Revenue in Prostate Cancer Medicine Business (2016-2021) & (US$ Million)
    Table 82. Teva Pharmaceuticals Industries Ltd. Recent Development
    Table 83. Johnson & Johnson Company Details
    Table 84. Johnson & Johnson Business Overview
    Table 85. Johnson & Johnson Prostate Cancer Medicine Product
    Table 86. Johnson & Johnson Revenue in Prostate Cancer Medicine Business (2016-2021) & (US$ Million)
    Table 87. Johnson & Johnson Recent Development
    Table 88. Pfizer Inc. Company Details
    Table 89. Pfizer Inc. Business Overview
    Table 90. Pfizer Inc. Prostate Cancer Medicine Product
    Table 91. Pfizer Inc. Revenue in Prostate Cancer Medicine Business (2016-2021) & (US$ Million)
    Table 92. Pfizer Inc. Recent Development
    Table 93. Bayer AG Company Details
    Table 94. Bayer AG Business Overview
    Table 95. Bayer AG Prostate Cancer Medicine Product
    Table 96. Bayer AG Revenue in Prostate Cancer Medicine Business (2016-2021) & (US$ Million)
    Table 97. Bayer AG Recent Development
    Table 98. Abbott Laboratories Company Details
    Table 99. Abbott Laboratories Business Overview
    Table 100. Abbott Laboratories Revenue in Prostate Cancer Medicine Business (2016-2021) & (US$ Million)
    Table 101. Abbott Laboratories Recent Development
    Table 102. Astellas Pharma Inc. Company Details
    Table 103. Astellas Pharma Inc. Business Overview
    Table 104. Astellas Pharma Inc. Prostate Cancer Medicine Product
    Table 105. Astellas Pharma Inc. Revenue in Prostate Cancer Medicine Business (2016-2021) & (US$ Million)
    Table 106. Astellas Pharma Inc. Recent Development
    Table 107. Roche Holding AG Company Details
    Table 108. Roche Holding AG Business Overview
    Table 109. Roche Holding AG Prostate Cancer Medicine Product
    Table 110. Roche Holding AG Revenue in Prostate Cancer Medicine Business (2016-2021) & (US$ Million)
    Table 111. Roche Holding AG Recent Development
    Table 112. Research Programs/Design for This Report
    Table 113. Key Data Information from Secondary Sources
    Table 114. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Prostate Cancer Medicine Market Share by Type: 2020 VS 2027
    Figure 2. LHRH Antagonists Features
    Figure 3. LHRH Analogs Features
    Figure 4. Antiandrogens Features
    Figure 5. Pipeline Drugs for Hormonal Therapy Features
    Figure 6. Global Prostate Cancer Medicine Market Share by Application: 2020 VS 2027
    Figure 7. Hospitals Case Studies
    Figure 8. Other Case Studies
    Figure 9. Prostate Cancer Medicine Report Years Considered
    Figure 10. Global Prostate Cancer Medicine Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 11. Global Prostate Cancer Medicine Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 12. Global Prostate Cancer Medicine Market Share by Regions: 2020 VS 2027
    Figure 13. Global Prostate Cancer Medicine Market Share by Regions (2022-2027)
    Figure 14. Global Prostate Cancer Medicine Market Share by Players in 2020
    Figure 15. Global Top Prostate Cancer Medicine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prostate Cancer Medicine as of 2020
    Figure 16. The Top 10 and 5 Players Market Share by Prostate Cancer Medicine Revenue in 2020
    Figure 17. Global Prostate Cancer Medicine Revenue Market Share by Type (2016-2021)
    Figure 18. Global Prostate Cancer Medicine Revenue Market Share by Type (2022-2027)
    Figure 19. North America Prostate Cancer Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 20. North America Prostate Cancer Medicine Market Share by Type (2016-2027)
    Figure 21. North America Prostate Cancer Medicine Market Share by Application (2016-2027)
    Figure 22. North America Prostate Cancer Medicine Market Share by Country (2016-2027)
    Figure 23. United States Prostate Cancer Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 24. Canada Prostate Cancer Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Europe Prostate Cancer Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. Europe Prostate Cancer Medicine Market Share by Type (2016-2027)
    Figure 27. Europe Prostate Cancer Medicine Market Share by Application (2016-2027)
    Figure 28. Europe Prostate Cancer Medicine Market Share by Country (2016-2027)
    Figure 29. Germany Prostate Cancer Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. France Prostate Cancer Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. U.K. Prostate Cancer Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Italy Prostate Cancer Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Russia Prostate Cancer Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Nordic Prostate Cancer Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Asia-Pacific Prostate Cancer Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Asia-Pacific Prostate Cancer Medicine Market Share by Type (2016-2027)
    Figure 37. Asia-Pacific Prostate Cancer Medicine Market Share by Application (2016-2027)
    Figure 38. Asia-Pacific Prostate Cancer Medicine Market Share by Region (2016-2027)
    Figure 39. China Prostate Cancer Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. Japan Prostate Cancer Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. South Korea Prostate Cancer Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. Southeast Asia Prostate Cancer Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. India Prostate Cancer Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Australia Prostate Cancer Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Latin America Prostate Cancer Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Latin America Prostate Cancer Medicine Market Share by Type (2016-2027)
    Figure 47. Latin America Prostate Cancer Medicine Market Share by Application (2016-2027)
    Figure 48. Latin America Prostate Cancer Medicine Market Share by Country (2016-2027)
    Figure 49. Mexico Prostate Cancer Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Brazil Prostate Cancer Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Middle East & Africa Prostate Cancer Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Middle East & Africa Prostate Cancer Medicine Market Share by Type (2016-2027)
    Figure 53. Middle East & Africa Prostate Cancer Medicine Market Share by Application (2016-2027)
    Figure 54. Middle East & Africa Prostate Cancer Medicine Market Share by Country (2016-2027)
    Figure 55. Turkey Prostate Cancer Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. Saudi Arabia Prostate Cancer Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. UAE Prostate Cancer Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. AstraZeneca plc Revenue Growth Rate in Prostate Cancer Medicine Business (2016-2021)
    Figure 59. Active Biotech Revenue Growth Rate in Prostate Cancer Medicine Business (2016-2021)
    Figure 60. Bristol Myers-Squibb Revenue Growth Rate in Prostate Cancer Medicine Business (2016-2021)
    Figure 61. Teva Pharmaceuticals Industries Ltd. Revenue Growth Rate in Prostate Cancer Medicine Business (2016-2021)
    Figure 62. Johnson & Johnson Revenue Growth Rate in Prostate Cancer Medicine Business (2016-2021)
    Figure 63. Pfizer Inc. Revenue Growth Rate in Prostate Cancer Medicine Business (2016-2021)
    Figure 64. Bayer AG Revenue Growth Rate in Prostate Cancer Medicine Business (2016-2021)
    Figure 65. Abbott Laboratories Revenue Growth Rate in Prostate Cancer Medicine Business (2016-2021)
    Figure 66. Astellas Pharma Inc. Revenue Growth Rate in Prostate Cancer Medicine Business (2016-2021)
    Figure 67. Roche Holding AG Revenue Growth Rate in Prostate Cancer Medicine Business (2016-2021)
    Figure 68. Bottom-up and Top-down Approaches for This Report
    Figure 69. Data Triangulation
    Figure 70. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
AstraZeneca plc
Active Biotech
Bristol Myers-Squibb
Teva Pharmaceuticals Industries Ltd.
Johnson & Johnson
Pfizer Inc.
Bayer AG
Abbott Laboratories
Astellas Pharma Inc.
Roche Holding AG
Frequently Asked Questions
Prostate Cancer Medicine report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Prostate Cancer Medicine report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Prostate Cancer Medicine report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Proton Therapy

Ionizing radiations are used to treat cancer and the procedure is known as radiation therapy. Whe ... Read More

Public Cloud Service

A public cloud is one based on the standard cloud computing model, in which a service provider ma ... Read More